
Regeneron Pharmaceuticals (REGN) Latest News & Updates
Explore latest Regeneron Pharmaceuticals (REGN) News and Updates
Stay updated on Regeneron Pharmaceuticals (REGN) with the latest news, market trends, and key developments to support informed investing decisions.
Start investing in Regeneron Pharmaceuticals (REGN)
Order type
Buy in
Order amount
Est. shares
0 shares
The Motley Fool •

Seeking Alpha •

Zacks Investment Research •

Investors Business Daily •

Zacks Investment Research •




Seeking Alpha •

The Motley Fool •

Dupixent® (dupilumab) Recommended for EU Approval by the CHMP for the Treatment of Prurigo Nodularis
PRNewsWire •

Zacks Investment Research •



InvestorPlace •

Zacks Investment Research •


Zacks Investment Research •


Investors Business Daily •





PRNewsWire •
